PTGS2 and adenoma: Clinical studies have demonstrated that non-steroidal anti-inflammatory drugs (NSAIDs) lower the chance of developing adenoma and colorectal tumors, and their effects are linked to the suppression of prostaglandin 2 and cyclooxygenase-2 (12–15).